Carregant...
The challenge of finding new therapeutic avenues in soft tissue sarcomas
Soft tissue sarcomas are rare malignancies of mesenchymal origin comprising about 1% of all adult cancers. Systemic therapies for locally advanced and metastatic disease have been restricted for decades to very few effective and approved agents such as doxorubicin and ifosfamide. However, new therap...
Guardat en:
| Publicat a: | Clin Sarcoma Res |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457009/ https://ncbi.nlm.nih.gov/pubmed/31007895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-019-0115-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|